Crestchem Receives Upgraded Stock Call, Shows Positive Results in First Half of 2024

May 30 2024 09:15 AM IST
share
Share Via
Crestchem, a microcap company in the chemicals industry, has received an upgraded stock call from MarketsMojo to a 'Hold' rating. The company has shown positive results in the first half of 2024, with a significant growth in net sales and profits. Technically, the stock is in a mildly bullish range and has an attractive valuation. However, its long-term fundamental strength and debt-servicing ability are weak, making it a potentially risky investment.
Crestchem Receives Upgraded Stock Call, Shows Positive Results in First Half of 2024
Crestchem, a microcap company in the chemicals industry, has recently received an upgraded stock call from MarketsMOJO. The stock has been upgraded to a 'Hold' rating, indicating a neutral stance on its performance.
The company has shown positive results in the first half of 2024, with a significant growth in net sales of 61.57% at Rs 12.99 crore. Its profits have also increased, with a higher PAT of Rs 1.57 crore. Additionally, the company's ROCE (Return on Capital Employed) is at its highest at 62.95%, indicating efficient use of capital. Technically, the stock is currently in a mildly bullish range, with multiple factors such as MACD, Bollinger Band, and OBV (On-Balance Volume) being bullish. This suggests a positive sentiment towards the stock in the market. Crestchem also has an attractive valuation, with a price to book value of 7.8 and a ROE (Return on Equity) of 45.3. The stock is currently trading at a discount compared to its average historical valuations, making it a potentially good investment opportunity. In the past year, the stock has generated a return of 54.07%, while its profits have risen by 146%. This indicates a strong growth potential for the company. The PEG (Price/Earnings to Growth) ratio of the company is also low at 0.1, further supporting its attractive valuation. It is worth noting that the majority of the company's shareholders are non-institutional investors, indicating a lack of interest from larger investors. Additionally, the company's long-term fundamental strength is weak, with a CAGR (Compound Annual Growth Rate) of only 15.55% in operating profits over the last 5 years. The company's ability to service its debt is also poor, with a low EBIT (Earnings Before Interest and Taxes) to Interest ratio of 0. In conclusion, while Crestchem has shown positive results and has a potential for growth, it is currently in a neutral position and may not be suitable for long-term investments. Investors should carefully consider the company's weak fundamental strength and debt-servicing ability before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News